All Company News
Mojdeh Poul is Appointed as the Next President and Chief Executive Officer, Effective January 6, 2025
Integra LifeSciences Reports Third Quarter 2024 Financial Results
Integra Named to World’s Largest Medical Device Companies List
For the fourth year in a row, Integra LifeSciences has been featured on Medical Design & Outsourcing’s MedTech 100 Largest Players list, which includes other top companies like Medtronic, Johnson & Johnson MedTech, Stryker, GE HealthCare and more.
Integra Recognized as Great Place To Work in Ireland
Celebrating 35 Years of Innovation
For more than three decades, Integra LifeSciences has positively impacted millions of patients around the world with medical technologies that restore lives. One of the company’s most significant products is Integra® Dermal Regeneration Template (IDRT), formerly known as “artificial skin” developed by Professor Ioannis Yannas, faculty member at the Massachusetts Institute of Technology and Dr. John Burke, a researcher who was then the head of the Shriners Burn Institute.
Integra LifeSciences Reports Second Quarter 2024 Financial Results
Integra LifeSciences Provides Updated Plans For Its Manufacturing Facility In Braintree, Massachusetts
Integra LifeSciences Reports First Quarter 2024 Financial Results
Integra LifeSciences Completes The Acquisition Of Acclarent, Inc.
Integra today announced it has successfully completed its acquisition of Acclarent, Inc., a pioneer in ear, nose and throat (ENT) surgical interventions. The addition of Acclarent's innovative product portfolio expands the breadth of Integra’s market-leading brands and provides immediate scale and accretive growth via a dedicated sales channel.
Integra LifeSciences Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides 2024 Financial Guidance
Integra LifeSciences reported financial results for the fourth quarter and full year 2023.
Integra Named one of Top 25 Medical Device Companies for 2024
Integra LifeSciences Announces Definitive Agreement To Acquire Acclarent®
PRINCETON, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced that it has entered into a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a Johnson & Johnson MedTech company for $275 million in cash at closing, subject to customary purchase price adjustments, and an additional $5 million upon the achievement of certain regulatory milestones. Acclarent is an innovator and market leader in ENT procedures and upon closing, Integra will be one of the leading providers of ENT products and technologies.